» Articles » PMID: 36430811

The Role of the Gallbladder, the Intestinal Barrier and the Gut Microbiota in the Development of Food Allergies and Other Disorders

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2022 Nov 26
PMID 36430811
Authors
Affiliations
Soon will be listed here.
Abstract

The microbiota present in the gastrointestinal tract is involved in the development or prevention of food allergies and autoimmune disorders; these bacteria can enter the gallbladder and, depending on the species involved, can either be benign or cause significant diseases. Occlusion of the gallbladder, usually due to the presence of calculi blocking the bile duct, facilitates microbial infection and inflammation, which can be serious enough to require life-saving surgery. In addition, the biliary salts are secreted into the intestine and can affect the gut microbiota. The interaction between the gut microbiota, pathogenic organisms, and the human immune system can create intestinal dysbiosis, generating a variety of syndromes including the development of food allergies and autoimmune disorders. The intestinal microbiota can aggravate certain food allergies, which become severe when the integrity of the intestinal barrier is affected, allowing bacteria, or their metabolites, to cross the intestinal barrier and invade the bloodstream, affecting distal body organs. This article deals with health conditions and severe diseases that are either influenced by the gut flora or caused by gallbladder obstruction and inflammation, as well as putative treatments for those illnesses.

Citing Articles

Establishment of a chronic biliary disease mouse model with cholecystoduodenal anastomosis for intestinal microbiome preservation.

Jang Y, Kim J, Han S, Park A, Baek S, Lee G World J Gastroenterol. 2024; 30(46):4937-4946.

PMID: 39679313 PMC: 11612716. DOI: 10.3748/wjg.v30.i46.4937.


Marine Bioactive Compounds with Functional Role in Immunity and Food Allergy.

Abril A, Carrera M, Pazos M Nutrients. 2024; 16(16).

PMID: 39203729 PMC: 11357426. DOI: 10.3390/nu16162592.


The causal relationship between gut microbiota and biliary tract cancer: comprehensive bidirectional Mendelian randomization analysis.

Wang K, Wang S, Qin X, Chen Y, Chen Y, Wang J Front Cell Infect Microbiol. 2024; 14:1308742.

PMID: 38558852 PMC: 10978781. DOI: 10.3389/fcimb.2024.1308742.


The origins and longevity of IgE responses as indicated by serological and cellular studies in mice and humans.

Ding Z, Mulder J, Robinson M Allergy. 2023; 78(12):3103-3117.

PMID: 37417548 PMC: 10952832. DOI: 10.1111/all.15799.

References
1.
Moffitt H . Clinical Features of Gallbladder and Gall Duct Affections. Cal State J Med. 1905; 3(9):277-80. PMC: 1650721. View

2.
R Muralitharan R, Jama H, Xie L, Peh A, Snelson M, Marques F . Microbial Peer Pressure: The Role of the Gut Microbiota in Hypertension and Its Complications. Hypertension. 2020; 76(6):1674-1687. DOI: 10.1161/HYPERTENSIONAHA.120.14473. View

3.
Magner W, Hutcheson J . CHOLECYSTITIS : A Bacteriological and Experimental Study. Can Med Assoc J. 2010; 27(5):469-77. PMC: 402585. View

4.
Moinard C, Cynober L, De Bandt J . Polyamines: metabolism and implications in human diseases. Clin Nutr. 2005; 24(2):184-97. DOI: 10.1016/j.clnu.2004.11.001. View

5.
Nikaido E, Yamaguchi A, Nishino K . AcrAB multidrug efflux pump regulation in Salmonella enterica serovar Typhimurium by RamA in response to environmental signals. J Biol Chem. 2008; 283(35):24245-53. PMC: 2527123. DOI: 10.1074/jbc.M804544200. View